Healthcare
With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.
Contact advisorDierenDokters has been acquired by VetPartners
DierenDokters, a leading group of fourteen veterinary clinics located across the Netherlands, has been acquired by VetPartners, a UK-based group of over 650 veterinary clinics and hospitals located across Europe. By partnering with VetPartners, DierenDokters welcomes a strong new shareholder that will help further enhance DierenDokters’ clinics’ service offering and allow the clinics to continue focusing on providing the best possible animal healthcare services.
Learn moreMBI Healthcare Technologies has been acquired by DNV AS
The founders of MBI Healthcare Technologies have sold the company to DNV AS. The acquisition forms part of DNV’s strategic expansion into the digital health market, where it aims to significantly grow its presence through innovation, acquisitions, and partnerships. DNV and MBI will work to rapidly scale MBI’s solutions in the UK, target growth in international markets and bring new data assurance technologies to the healthcare sector.
Learn moreAlcidion acquires Silverlink Software
Alcidion Group Ltd. (ASX:ALC) has acquired Silverlink PCS Software Limited.
Learn moreHenrik Svärdskog
CEO and Co-owner, Kungshusen Medicinska AB
Read moreStrategic moves and sector-specific trends
QUARTERLY M&A ACTIVITY: From securing growth capital to finding future partners, Oaklins' Q3 deals reflect strategic navigation in dynamic industry landscapes.
Learn moreTalk to our local advisors
Meet our global industry specialists
Michael S. Goldman
Oaklins TM Capital